Sort
16,300 grants matching “fatty liver disease”
Data Coordinating Center for the Nonalcoholic Steatohepatitis Clinical Research Network (NASH CRN) Continuation
$999,999David M Shade · Johns Hopkins University · U24 · FY2025 · DK
TLC-1235, a controlled-release mitochondrial protonophore (CRMP), for the reversal of insulin resistance in patients with severe lipodystrophy
$999,999Robert Paul Myers · Orsobio, Inc. · R44 · FY2023 · DK
Genetically Attenuated Malaria Attenuated Whole Parasite Sporozoite Vaccine
$999,987Stephen Lev Hoffman · Sanaria, Inc. · R44 · FY2010 · AI
"Validation of Novel CKD Biomarkers in CRIC"
$999,432Chi-Yuan Hsu · University Of California, San Francisco · U01 · FY2009 · DK
Center for Cellular Metabolism Research in Oklahoma
$997,408Lijun Xia · Oklahoma Medical Research Foundation · P20 · FY2024 · GM
ER mitochondrial signaling and alcoholic tissue injury
$997,350Gyorgy Hajnoczky · Thomas Jefferson University · RC2 · FY2009 · AA
Subclinical Vascular Disease and Metabolic Abnormalities in MACS
$996,118Wendy S Post · Johns Hopkins University · R01 · FY2011 · HL
Administrative Core
$995,617Michael I Goran · Children'S Hospital Of Los Angeles · P50 · FY2024 · MD
Genetically Attenuated Malaria Attenuated Whole Parasite Sporozoite Vaccine
$995,117Stephen Lev Hoffman · Sanaria, Inc. · R44 · FY2011 · AI
Characterizing Alcohol's Effects on Repair of Liver Injury
$993,948Anna Mae Elizabeth Diehl · Duke University · RC2 · FY2009 · AA
Metabolomics of obstructive sleep apnea
$993,904Aalim M Weljie · University Of Pennsylvania · R01 · FY2023 · HL
Targeting SWELL1 Signaling to Treat Obesity-Induced Type 2 Diabetes
$993,178Daniel J Lerner · Senseion Therapeutics, Inc. · R44 · FY2021 · DK
Regulation Of Intracellular Iron Metabolism
$991,868Tracey A. Rouault · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2016 · HD
Role of the Omentum in the Treatment of Morbid Obesity
$991,557Naji N Abumrad · Vanderbilt University · R01 · FY2009 · DK
Targeting SWELL1 Signaling to Treat Obesity-Induced Type 2 Diabetes
$990,929Daniel J Lerner · Senseion Therapeutics, Inc. · R44 · FY2022 · DK
Nuclear receptors: action, functions, and roles in disease
$989,992Anton M Jetten · National Institute Of Environmental Health Sciences · ZIA · FY2016 · ES
Development of a Novel MRI Contrast Agent for Early Detection of Alcoholic Steatohepatitis
$989,930Jenny J Yang · Inlighta Biosciences, Llc · UT2 · FY2020 · AA
Systems Biology Approach to Identifying Biomarkers for Alcoholic Liver Disease
$988,920Ali Keshavarzian · Rush University Medical Center · RC2 · FY2009 · AA
Xenobiotic Receptors
$988,205Frank J Gonzalez · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Novel Biguanides to Treat Type 2 Diabetes
$987,938Ken W Batchelor · Novatarg, Inc. · R44 · FY2016 · DK
Systems Biology Approach to Identifying Biomarkers for Alcoholic Liver Disease
$985,241Ali Keshavarzian · Rush University Medical Center · RC2 · FY2010 · AA
Development of a Novel MRI Contrast Agent for Early Detection of Alcoholic Steatohepatitis
$984,309Jenny J Yang · Inlighta Biosciences, Llc · UT2 · FY2021 · AA
University of Michigan Center for Gastrointestinal Research
$983,685John W Wiley · University Of Michigan At Ann Arbor · P30 · FY2021 · DK
ER mitochondrial signaling and alcoholic tissue injury
$982,941Gyorgy Hajnoczky · Thomas Jefferson University · RC2 · FY2010 · AA
A Precision Medicine for Alcohol-Associated Liver Disease
$982,659Wanqing Liu · Genetobe Inc. · UT2 · FY2024 · AA